Macrobid vs. Zithromax
See how Macrobid and Zithromax compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Macrobid only treats urinary tract infections, while Zithromax covers a much wider range of bacterial infections throughout the body.
Macrobid is taken twice daily for a full week, whereas Zithromax often works as a single dose or a short 5-day course.
Zithromax carries an FDA warning for heart rhythm changes that Macrobid does not, but Macrobid is unsafe for anyone with reduced kidney function.
Macrobid vs. Zithromax Drug Summary
Macrobid
Macrobid is a nitrofuran antibiotic that treats uncomplicated urinary tract infections caused by susceptible bacteria like E. coli. It is taken as an oral capsule, usually 100 mg every 12 hours for seven days. It concentrates in urine rather than the bloodstream, so it is not used for infections outside the urinary tract.
Zithromax
Zithromax is a macrolide antibiotic used for a wide range of bacterial infections, including pneumonia, bronchitis, sinusitis, and certain sexually transmitted infections. It comes as a tablet, liquid, or IV formulation, often given as a short 5-day course or a single dose. Its long tissue half-life lets it clear infections after just a few doses.
Macrobid vs. Zithromax Side Effects
Macrobid
Zithromax
Macrobid vs. Zithromax Dosage
Macrobid
Zithromax
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
| STAGE | DOSE | WHEN |
| Starting dose | 500 mg once daily | Day 1 |
| Maximum dose | 30 mg/kg single dose | If needed |
| Dose changes | 5 increases | As tolerated |
Macrobid
| STAGE | DOSE | WHEN |
| Starting dose | 100 mg every 12 hours | Days 1-7 |
| Maximum dose | 100 mg every 12 hours | Same as starting |
| Dose changes | None | Fixed dose |
Zithromax
| STAGE | DOSE | WHEN |
| Starting dose | 500 mg once daily | Day 1 |
| Maximum dose | 30 mg/kg single dose | If needed |
| Dose changes | 5 increases | As tolerated |
Macrobid vs. Zithromax Indications
Macrobid
Macrobid is FDA-approved only for treating acute, uncomplicated urinary tract infections caused by susceptible strains of E. coli or S. saprophyticus. Doctors also prescribe it off-label at low doses for long-term prevention of recurrent UTIs. It is not approved for kidney infections or for use in young children.
Acute uncomplicated UTI (cystitis)
Caused by E. coli or S. saprophyticus
Off-label: recurrent UTI prevention
Not for pyelonephritis or kidney infections
Zithromax
Zithromax is FDA-approved for a broad set of bacterial infections, including bronchitis, pneumonia, sinusitis, ear infections, skin infections, and certain sexually transmitted infections. It is also approved to prevent and treat disseminated MAC disease in people with weakened immune systems. Off-label, it is sometimes used for traveler's diarrhea and eye infections.
Community-acquired pneumonia
Acute bronchitis and sinusitis
Chlamydia and gonorrhea infections
MAC disease prevention and treatment
Macrobid vs. Zithromax Pros and Cons
Macrobid
Macrobid remains a dependable, narrow-spectrum option for uncomplicated UTIs, largely because bacterial resistance to it has stayed low despite decades of use. It is not an option for anyone with reduced kidney function, and its coverage is limited strictly to the urinary tract.
Pros
Reliable long-term effectiveness against E. coli despite decades of use
Stays concentrated in urine, so it disrupts gut bacteria less than broader antibiotics
No cardiac rhythm warnings on the label
Straightforward course without repeated redosing
Cons
Cannot be used with reduced kidney function (CrCl under 60 mL/min)
Rare but serious risk of lung and liver toxicity with long-term use
Not effective for infections outside the urinary tract
Requires twice-daily dosing for a full week
Zithromax
Zithromax's broad spectrum and short dosing courses make it convenient for many common respiratory, skin, and sexually transmitted infections. Its heart rhythm warning and rising resistance rates are important trade-offs to weigh against that convenience.
Pros
Treats infections throughout the body, not just one organ system
Some regimens finish in a single dose or within 5 days
Long tissue half-life means fewer doses are needed overall
Also used to prevent serious MAC infections in immunocompromised patients
Cons
Carries an FDA warning for QT prolongation and heart rhythm risk
Growing bacterial resistance has reduced reliability for some infections
More gastrointestinal side effects reported, including diarrhea and vomiting
Not appropriate for viral infections despite common misuse
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.